Work

Poster: MPN-038: PACIFICA: A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician’s Choice in Patients with Primary or Secondary Myelofibrosis and Severe Thrombocytopenia

Year: 2021

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(21)01480-4

Authors: John Mascarenhas, Aaron Gerds, Jean-Jacques Kiladjian, Konstanze Döhner, Sarah Buckley, Jennifer Smith, Adam Craig, Simran Singh, Srdan Verstovsek, Claire Harrison

Institutions: Icahn School of Medicine at Mount Sinai, Cleveland Clinic, Hôpital Saint-Louis, University Hospital Ulm, CTI BioPharma (United States), The University of Texas MD Anderson Cancer Center, Guy's and St Thomas' NHS Foundation Trust

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4200385620

FWCI:

Cites:

Cited by:

Related to: 10